The Cigna Group (CI)
322.01 x 1 333.59 x 1
Post-market by (Cboe BZX)
325.04 +0.30 (+0.09%) 03/28/25 [NYSE]
322.01 x 1 333.59 x 1
Post-market 325.04 unch (unch) 16:04 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 247,121,000 | 195,265,000 | 180,518,000 | 174,069,000 | 160,401,000 |
Total expenses | 237,704,000 | 186,729,000 | 172,068,000 | 166,128,000 | 152,248,000 |
Pre-tax Income | 5,269,000 | 5,513,000 | 8,397,000 | 6,790,000 | 10,868,000 |
Income Tax | 1,491,000 | 141,000 | 1,615,000 | 1,370,000 | 2,379,000 |
Net Income Continuous | 3,778,000 | 5,372,000 | 6,782,000 | 5,420,000 | 8,489,000 |
Minority Interests | 344,000 | 208,000 | 78,000 | 50,000 | 31,000 |
Net Income | $3,434,000 | $5,164,000 | $6,704,000 | $5,370,000 | $8,458,000 |
EPS Basic Continuous Ops | 13.48 | 18.28 | 21.91 | 16.04 | 23.26 |
EPS Basic Total Ops | 12.25 | 17.57 | 21.66 | 15.89 | 23.17 |
EPS Diluted Continuous Ops | 13.34 | 18.09 | 21.66 | 15.90 | 23.04 |
EPS Diluted Total Ops | 12.12 | 17.39 | 21.41 | 15.75 | 22.96 |
EPS Diluted Before Non-Recurring Items | 27.33 | 25.09 | 23.27 | 20.47 | 18.45 |
EBITDA(a) | $12,192,000 | $11,571,000 | $11,387,000 | $10,864,000 | $10,955,000 |